Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Hereditary Sensory and Autonomic Neuropathies × dapagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Obesity 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Breast Neoplasms 1

Interventions

Fulvestrant 3 Alpelisib 3 parsaclisib 2 berzosertib 2 NVP-BKM120 2 talazoparib 1 sotorasib 1 ruxolitinib 1 duvelisib 1 dapagliflozin 1 ceralasertib 1 binimetinib 1 avelumab 1 Vemurafenib 1 Topotecan 1 SF 1126 1 Rituximab 1 Paclitaxel 1 Leuprolide 1 Letrozole 1 Goserelin 1 Everolimus 1 Capecitabine 1 CB-839 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04899349 2024-10-09

EPIK-B4

Novartis

Phase 2 Terminated

2 enrolled 8 charts

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡